---
title: Halobetasol + Mupirocin
description: >-
  Halobetasol + Mupirocin is a topical combination medication indicated for the
  short-term treatment of inflammatory skin disorders complicated by secondary
  bacterial infections.  These conditions include eczema, psoriasis, and
  dermatitis with bacterial superinfection, such as impetigo.  It is not ...
is_banned: false
lastModified: '2025-09-22T17:22:09.350Z'
faqs:
  - q: >-
      What is the recommended dosage for Halobetasol + Mupirocin?**


      **A:** Apply a thin layer to affected areas twice daily for a maximum of
      two weeks. Do not exceed 50g per week.  Shorter durations are recommended
      for children.
    a: >-
      A:** Apply a thin layer to affected areas twice daily for a maximum of two
      weeks. Do not exceed 50g per week.  Shorter durations are recommended for
      children.
  - q: >-
      Can Halobetasol + Mupirocin be used on the face?**


      **A:** Generally, it should be avoided on the face unless specifically
      directed by a physician, due to the increased risk of skin atrophy and
      other side effects.
    a: >-
      A:** Generally, it should be avoided on the face unless specifically
      directed by a physician, due to the increased risk of skin atrophy and
      other side effects.
  - q: |-
      How long can I use Halobetasol + Mupirocin?**

      **A:** Treatment should generally not exceed two weeks.
    a: 'A:** Treatment should generally not exceed two weeks.'
  - q: >-
      What should I do if my symptoms don't improve after using Halobetasol +
      Mupirocin?**


      **A:** Consult your physician. The diagnosis may need to be re-evaluated,
      or an alternative treatment considered.
    a: >-
      A:** Consult your physician. The diagnosis may need to be re-evaluated, or
      an alternative treatment considered.
  - q: >-
      Can I use Halobetasol + Mupirocin if I'm pregnant or breastfeeding?**


      **A:** Consult your physician. The safety of this medication during
      pregnancy and breastfeeding has not been established.
    a: >-
      A:** Consult your physician. The safety of this medication during
      pregnancy and breastfeeding has not been established.
  - q: >-
      Can Halobetasol + Mupirocin be used on open wounds?**


      **A:** No, it is contraindicated for use on open wounds, lesions, or
      blisters.
    a: >-
      A:** No, it is contraindicated for use on open wounds, lesions, or
      blisters.
  - q: >-
      What are the common side effects?**


      **A:** Common side effects include burning, stinging, itching, dryness,
      and skin irritation at the application site.
    a: >-
      A:** Common side effects include burning, stinging, itching, dryness, and
      skin irritation at the application site.
  - q: >-
      Are there any serious side effects I should be aware of?**


      **A:** While rare, serious side effects can include skin atrophy, allergic
      reactions, and HPA axis suppression with prolonged or extensive use.
    a: >-
      A:** While rare, serious side effects can include skin atrophy, allergic
      reactions, and HPA axis suppression with prolonged or extensive use.
  - q: >-
      Can this be used for diaper rash?**


      **A:** No, Halobetasol + Mupirocin is not recommended for use in diaper
      rash.
    a: >-
      A:** No, Halobetasol + Mupirocin is not recommended for use in diaper
      rash.
  - q: >-
      Should I cover the treated area with a bandage?**


      **A:**  Do not use occlusive dressings unless specifically instructed by
      your physician.
    a: >-
      A:**  Do not use occlusive dressings unless specifically instructed by
      your physician.
---
## **Usage**

Halobetasol + Mupirocin is a topical combination medication indicated for the short-term treatment of inflammatory skin disorders complicated by secondary bacterial infections.  These conditions include eczema, psoriasis, and dermatitis with bacterial superinfection, such as impetigo.  It is not recommended for diaper rash.

* **Pharmacological Classification:**
    * Halobetasol: Corticosteroid, topical
    * Mupirocin: Antibiotic, topical

* **Mechanism of Action:**
    * Halobetasol:  A high-potency corticosteroid that suppresses the inflammatory response by inhibiting prostaglandin and leukotriene synthesis. This reduces vasodilation, edema, and pruritus (itching).
    * Mupirocin: A bacterial protein synthesis inhibitor that binds to bacterial isoleucyl transfer-RNA synthetase. This action is bactericidal against susceptible bacteria, primarily *Staphylococcus aureus* and *Streptococcus pyogenes*.


## **Alternate Names** 

* GRM Ointment
* Various brand names depending on the manufacturer (e.g., Grm Ointment)

## **How It Works**

* **Pharmacodynamics:**
    * Halobetasol: Binds to glucocorticoid receptors in the skin, reducing inflammation.
    * Mupirocin: Reversibly binds to bacterial isoleucyl transfer-RNA synthetase, inhibiting protein synthesis and causing bacterial cell death.

* **Pharmacokinetics:**
    * Halobetasol: Minimally absorbed systemically with topical application to intact skin.
    * Mupirocin: Minimal systemic absorption through intact skin. Primarily metabolized to inactive monic acid. Excreted in urine and feces.

* **Mode of Action:**
    * Halobetasol exerts its anti-inflammatory effects by binding to intracellular glucocorticoid receptors. The drug-receptor complex translocates to the nucleus, modulating gene expression and affecting the synthesis of inflammatory mediators.
    * Mupirocin inhibits bacterial protein synthesis by specifically and reversibly binding to isoleucyl-tRNA synthetase.

* **Elimination Pathways:**
    * Halobetasol: Primarily metabolized in the liver; excreted in urine and feces.
    * Mupirocin: Primarily metabolized to inactive monic acid; excreted in urine and feces.

## **Dosage**

### **Standard Dosage**

#### **Adults:**

Apply a thin layer to the affected skin areas twice daily for a maximum of two weeks. Do not exceed 50g per week.

#### **Children:**

Use is generally not recommended for children under 12 years of age. For children 12 years and older, the dosage is the same as for adults, but shorter durations of treatment are preferred. Close monitoring for adverse effects, particularly HPA axis suppression, is crucial.  Not generally recommended for children below 13 years due to Halobetasol content. If used in younger children, the treatment duration may be limited to five days under close medical supervision.

#### **Special Cases:**

* **Elderly Patients:** Use with caution. Monitor for skin atrophy and HPA axis suppression.
* **Patients with Renal Impairment:** Caution advised, particularly with large open wounds, due to potential for increased systemic absorption of polyethylene glycol from the ointment base.  Monitor renal function.
* **Patients with Hepatic Dysfunction:** No specific dosage adjustment typically required.
* **Patients with Comorbid Conditions:** Caution in patients with diabetes, Cushing's syndrome, and hyperglycemia, as corticosteroids can exacerbate these conditions.

### **Clinical Use Cases**

This medication is not typically used in the clinical settings of intubation, surgical procedures, mechanical ventilation, intensive care unit (ICU) use, or emergency situations.

### **Dosage Adjustments**

Dose modifications may be necessary based on patient-specific factors such as renal or hepatic dysfunction, metabolic disorders, or genetic polymorphisms affecting drug metabolism.  Always consult specialist advice for such cases.

## **Side Effects**

### **Common Side Effects:**

* Burning
* Stinging
* Itching
* Dryness
* Skin irritation
* Redness at the application site


### **Rare but Serious Side Effects:**

* Skin atrophy
* Allergic reactions (angioedema, urticaria)
* HPA axis suppression (with prolonged/extensive use)


### **Long-Term Effects:**

* Skin thinning
* Telangiectasia (spider veins)
* Striae (stretch marks)
* Hypopigmentation


### **Adverse Drug Reactions (ADR):**

* Angioedema
* Urticaria
* Systemic allergic reactions (rare)

## **Contraindications**

* Hypersensitivity to halobetasol, mupirocin, or any component of the formulation.
* Viral skin infections (e.g., herpes simplex, varicella zoster).
* Rosacea.
* Acne.
* Perioral dermatitis.
* Open wounds, lesions, or blisters.

## **Drug Interactions**

No significant drug-drug interactions are known.  However, patients should inform their physician about all medications, including topical products, that they are using.

## **Pregnancy and Breastfeeding**

* **Pregnancy:** Safety not established. Use only if the potential benefit outweighs the potential risk to the fetus.
* **Breastfeeding:** Safety not established. It is unknown if halobetasol or mupirocin are excreted in breast milk. Use with caution. Consult with a specialist before usage.

## **Drug Profile Summary**

* **Mechanism of Action:** Topical corticosteroid (halobetasol) reduces inflammation; topical antibiotic (mupirocin) inhibits bacterial protein synthesis.
* **Side Effects:** Burning, stinging, itching, dryness, skin irritation. Rarely: skin atrophy, allergic reactions, HPA axis suppression.
* **Contraindications:** Hypersensitivity, viral skin infections, rosacea, acne, perioral dermatitis, open wounds.
* **Drug Interactions:** None known. Always consult a specialist if other medications are being used.
* **Pregnancy & Breastfeeding:** Use with caution. Safety not established. Consult a specialist before use.
* **Dosage:** Apply a thin layer twice daily for up to two weeks. Maximum 50g per week.
* **Monitoring Parameters:** Skin integrity, signs of infection, signs of HPA axis suppression (with prolonged/extensive use).

## **Popular Combinations**

Halobetasol + Mupirocin is itself a popular fixed-dose combination.

## **Precautions**

* **General Precautions:** Pre-screening for allergies, metabolic disorders, organ dysfunction.
* **Specific Populations:**
    * **Pregnant Women:** Risks, safety considerations; consult a specialist.
    * **Breastfeeding Mothers:** Risk of neonatal exposure; consult a specialist.
    * **Children & Elderly:** Age-specific precautions; use shorter durations in children and monitor elderly for adverse effects.
* **Lifestyle Considerations:**  Avoid alcohol on affected areas.  Smoking may delay healing. Advise patients to wear loose-fitting clothes and avoid scratching.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Halobetasol + Mupirocin?**

**A:** Apply a thin layer to affected areas twice daily for a maximum of two weeks. Do not exceed 50g per week.  Shorter durations are recommended for children.

### **Q2: Can Halobetasol + Mupirocin be used on the face?**

**A:** Generally, it should be avoided on the face unless specifically directed by a physician, due to the increased risk of skin atrophy and other side effects.

### **Q3: How long can I use Halobetasol + Mupirocin?**

**A:** Treatment should generally not exceed two weeks.

### **Q4: What should I do if my symptoms don't improve after using Halobetasol + Mupirocin?**

**A:** Consult your physician. The diagnosis may need to be re-evaluated, or an alternative treatment considered.

### **Q5: Can I use Halobetasol + Mupirocin if I'm pregnant or breastfeeding?**

**A:** Consult your physician. The safety of this medication during pregnancy and breastfeeding has not been established.

### **Q6: Can Halobetasol + Mupirocin be used on open wounds?**

**A:** No, it is contraindicated for use on open wounds, lesions, or blisters.

### **Q7:  What are the common side effects?**

**A:** Common side effects include burning, stinging, itching, dryness, and skin irritation at the application site.

### **Q8: Are there any serious side effects I should be aware of?**

**A:** While rare, serious side effects can include skin atrophy, allergic reactions, and HPA axis suppression with prolonged or extensive use.

### **Q9: Can this be used for diaper rash?**

**A:** No, Halobetasol + Mupirocin is not recommended for use in diaper rash.

### **Q10: Should I cover the treated area with a bandage?**

**A:**  Do not use occlusive dressings unless specifically instructed by your physician.




